UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.802
EU - Europa 4.955
AS - Asia 3.632
SA - Sud America 404
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 12
Totale 25.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.751
SG - Singapore 1.228
CN - Cina 1.201
UA - Ucraina 1.185
IT - Italia 1.046
DE - Germania 784
RU - Federazione Russa 727
IE - Irlanda 428
VN - Vietnam 422
FI - Finlandia 419
BR - Brasile 369
TR - Turchia 263
KR - Corea 261
SE - Svezia 163
HK - Hong Kong 103
IN - India 62
AT - Austria 43
CZ - Repubblica Ceca 39
GB - Regno Unito 39
CA - Canada 37
EU - Europa 28
JP - Giappone 25
ET - Etiopia 23
NL - Olanda 21
AR - Argentina 13
FR - Francia 13
AU - Australia 8
ES - Italia 8
ID - Indonesia 8
PK - Pakistan 8
UZ - Uzbekistan 8
BD - Bangladesh 7
EG - Egitto 7
CH - Svizzera 6
EC - Ecuador 6
JO - Giordania 5
KE - Kenya 5
MX - Messico 5
PS - Palestinian Territory 5
CL - Cile 4
HU - Ungheria 4
IQ - Iraq 4
LU - Lussemburgo 4
MA - Marocco 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
BE - Belgio 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
MY - Malesia 3
PL - Polonia 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
SN - Senegal 2
UY - Uruguay 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
KZ - Kazakistan 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 25.882
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.703
Woodbridge 2.446
Jacksonville 1.459
Chandler 1.347
Princeton 1.164
Houston 1.161
Wilmington 1.110
Ashburn 471
Dong Ket 422
Singapore 412
Dublin 406
Munich 287
Andover 283
Nanjing 258
Boardman 245
Izmir 245
Moscow 215
Salerno 208
Beijing 207
Pellezzano 171
Helsinki 150
Düsseldorf 145
Naples 129
Fairfield 100
Hong Kong 94
Shenyang 90
Nanchang 86
Changsha 84
Jiaxing 80
Hebei 77
Redwood City 55
Washington 54
Los Angeles 53
Nuremberg 49
Norwalk 48
Tianjin 46
Rome 43
Dallas 39
Pune 39
Dearborn 37
Brno 36
Napoli 36
Cambridge 34
Seattle 30
San Diego 27
São Paulo 26
Addis Ababa 23
Guangzhou 22
Milan 22
Jinan 21
Rio de Janeiro 21
Mestre 20
Falls Church 18
Grevenbroich 17
Jyväskylä 17
Vienna 17
Belo Horizonte 14
Fisciano 14
Lappeenranta 14
New York 14
Ottawa 14
Zhengzhou 13
Shanghai 12
Tappahannock 11
Caserta 10
Hillsboro 10
Amsterdam 9
Brasília 9
Santa Clara 9
Tokyo 9
Toronto 9
Cava de' Tirreni 8
Hefei 8
Indiana 8
London 8
Manchester 8
Pisa 8
Tashkent 8
Council Bluffs 7
Haikou 7
Palermo 7
Phoenix 7
Richmond 7
Teano 7
Baltimore 6
Contagem 6
Curitiba 6
Edinburgh 6
Madrid 6
West Jordan 6
Wuhan 6
Amman 5
Catania 5
Cava De' Tirreni 5
Clifton 5
Costa Mesa 5
Domicella 5
Etobicoke 5
Fort Worth 5
Mumbai 5
Totale 19.461
Salva come PNG Salva come JPEG
Nome #
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 249
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 168
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 167
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 134
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 133
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 132
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 132
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 130
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 130
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 128
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 124
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 123
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 122
High dose rHuEPO may induce complete remission in AML-M6 121
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 119
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 116
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 115
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 114
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 113
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 113
Allogeneic transplantation for multiple myeloma 112
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 112
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 111
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 110
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 110
Adjuvant treatment of diabetic foot 110
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 109
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 108
IgH assessment of non-Hodgkin lymphoma cells on FTA cards. 108
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 107
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 107
Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study 107
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 107
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 106
Long-term follow-up of a pilot study with alemtuzumab and low-dose cyclosporine a for aplastic anaemia and single-lineage marrow failures. 106
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 106
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 106
Impact of cytokine gene polymorphism in aplastic anemia (AA) 106
The urokinase-receptor in infectious diseases. 106
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 106
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 105
67 kDa laminin receptor: structure, function and role in cancer and infection. 105
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 105
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 105
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 104
Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond. 104
A backwards evolution in a case of myeloproliferative disease 104
Imatinib as salvage therapy for patients with refractory cGVHD 104
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. 102
Ultrasound image of pleural granulocytic sarcoma. 102
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 102
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) 102
Estrogen-progestin-replacement therapy in women after stem cell transplant 101
Fas-Ligand expressed on acute leukemia cells may kill Fas positive Jurkat cells. 101
FAS antigen expression on normal and aplastic CD34+ cells. 101
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 101
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 100
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies. 100
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 100
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 99
Inhibition of interferon regulatory factor-1 expression induces interferon-gamma to stimulate CD34+ cells. 99
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 99
Nitric oxide and cell survival: megakaryocytes say "NO". 98
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 98
The pathophysiology of aquired aplastic anemia. 98
Farnesyltransferase inhibition may revert in vitro Fas-mediated apoptosis of clonogenic chronic myeloid leukemia cells. 98
Bone marrow long-term initiating cells are decreased after allogeneic bone marrow transplantation. 98
Cyclosporin-A may improve in vitro circulating hematopoietic progenitors growth and affects CD4 cells expressing interferon-gamma of hypoplastic myelodysplastic patients. 98
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 98
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 98
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 98
Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. 97
Circulating T regulatory cells (TREG) are decreased in patients with aplastic anemia (AA). 97
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 97
Previous occurrence of life-threatening abdominal infection is not a contraindication to marrow transplant. 96
Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease: final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD 96
Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity 96
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 95
Role of the urokinase receptor in hematopoietic stem cell transplantation 95
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GvHD. 95
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 95
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 95
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 94
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 94
Interferon-alpha may modulate the balance between FAS-receptor and FAS-ligand expression on bone marrow chronic myeloid leukemia cells. 94
Avascular necrosis after allogeneic hematopoietic stem cell transplantation: An observational study on the effects of zoledronic acid 94
Subcutaneous Alemtuzumab Is a safe and effective treatment for global or single lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA. 94
Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond 93
Imbalance of the osteprotegerin/RANKL system in bone marrow microenvironment after allogeneic transplant of hemopoietic stem cell 93
Interferon regulatory factor-1 partially mediates interferon-gamma hematopoietic inhibition. 93
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 93
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. 92
Fanconi's anemia cells are relatively resistant to H2O2-induced damage. 92
Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report. 92
Determination of LTC-IC numbers in patients with myelodysplastic syndromes 92
Constitutive expression of interferon-gamma in stromal human marrow culures mediates hematopoietic suppression and apoptosis of CD34+ cells. 92
Immunologic reconstitution after autologous transplant with bone marrow or peripheral blood stem cells 91
Immunosuppression by alemtuzumab for the treatment of bone marrow failure of bone marrow failure syndromes 91
Increased expression of Fas-ligand on bone marrow progenitor cells of patients with chronic myeloid leukemia. 91
Endocrine disorders after autologous and allogeneic stem cell transplantation 91
Totale 10.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020386 0 0 0 0 0 0 0 0 0 0 353 33
2020/20212.335 28 242 248 11 328 74 266 25 247 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.769 182 250 131 101 144 264 75 93 16 68 105 340
2024/20253.624 165 77 63 149 223 610 880 501 672 253 31 0
Totale 26.560